Fig. 4From: Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progressionStrategy used for RCC biomarkers discovery and validation. The Fig. depicts the general strategy used to determine clinically relevant signatures from each generated cell line (i.e. KPT, K-LM and T-LM). For detailed description see Materials and Methods sectionBack to article page